Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Trends and Future of Pharmaceutical Continuous Manufacturing Lawrence De Belder, at Pharmatech Associates, Inc. and Jan Vogeleer at Fette Compacting In this webinar, Lawrence De Belder will give an overview of the history, present, and expected future of continuous manufacturing for drug product, d... 1 month ago | 107 mins Enabling Robust Biomanufacturing Through Systematic Understanding of Single-Use Dr. Jun Tian, Executive Director and Head of Upstream Process Development at WuXi Biologics Full title: Enabling Robust Biomanufacturing Through Systematic Understanding of Single-Use Systems and Stringent Process and Raw Material Controls S... 4 months ago | 43 mins Development of a blending design space model to control uniformity... Manel Bautista, Senior PAT Expert, Principal Scientist at Roche Full title: Development of a blending design space model to control uniformity in a Mini-Batch Direct Compression line Blending is a common manufactu... October 23, 2023 2:00pm De-bottlenecking Challenges in Large Scale Viral Vector Manufacturing... Prateek Gupta, PhD Senior Vice President, Process Development & MSAT at Stelis Biopharma Ltd. Full Title: De-bottlenecking Challenges in Large Scale Viral Vector Manufacturing for Gene Therapy Applications The rush to develop an affordable and... September 12, 2023 8:30pm Novel Technologies That Aid the Detection and Differentiation of Proteinaceous.. Danny Chou, President and Founder at Compassion BioSolution, LLC Full Title: Novel Technologies That Aid the Detection and Differentiation of Proteinaceous Impurities in Biologic Drug Substances and Drug Product Pr... 3 years ago | 87 mins Next Generation Bioprocess Facility Design - A Case Study From Samsung Biologics Ken Green, Ph.D, Science and Technology at Samsung Biologics. John Bonham-Carter. Product Line Leader, Repligen A case study be presented describing initiatives and bioprocessing approaches to maximize capacity utilization within a new large scale (12x 15kL) dru... 3 years ago | 97 mins Operational Excellence in Process Development in Drug Substance Production Presented by Ken Green, Ph.D, Head of MSAT at Samsung Biologics and Klaus Mauch, CEO at Insilico Biotechnology AG This presentation will highlight Samsung Biologics (SBL) approach to align process development activities with technology transfer and cGMP manufactur... 2 years ago | 107 mins An impurity detected in a stability study... Petra Booij, Investigator bij GlaxoSmithKline and Ward D’Autry, PhD Study Director at Nelson Labs Europe Full Title: An impurity detected in a stability study: Did we miss anything in our E&L risk assessment? Extractable and leachable (E&L) testing are r... 1 year ago | 90 mins Identification of Approaches to Simulated Leachable Studies Jason Creasey, Managing Director at Maven E&L and Karen Pieters, Ir. Team Leader E&L at Nelson Labs Europe Full Title: Identification of Approaches to Simulated Leachable Studies: What are They? When to do Them? Presented by Jason Creasey, Managing Directo... 3 years ago | 80 mins Developing Practical Single-Use Processes for New Vaccine Formulations Kirsten Strahlendorf New vaccine process designs – and all the kinks that go with them – are typically hammered out in a small scale capacity, for example, prior to manufa... 6 years ago | 76 mins
